.svg)
Sol.i.Pharma is a 100% Italian company that develops innovative and highly technological pharmaceutical solutions for hospital healthcare. Our specialization is automated compounding of chemotherapy drugs.
Sol.i.Pharma was born from the convergence of excellence-driven expertise, with the ambition to bring concrete and reliable innovation to the field of highly specialized pharmaceutical solutions.
The business network takes shape through the integration of Sipar Srl, a historic company founded in Milan in 1956 and a national reference point for the distribution and management of advanced medical technologies, and CIA Automation and Robotics, an advanced engineering center with over forty years of experience in the development of highly automated robotic systems.
This union represents a strategic balance between clinical knowledge and engineering capability.
On one hand, a deep understanding of the operational needs of healthcare facilities; on the other, the design of advanced technological solutions capable of ensuring precision, safety, and continuity in the most critical processes.
Sol.i.Pharma establishes itself as a company capable of transforming multidisciplinary know-how into applied innovation, developing advanced systems designed to effectively address the contemporary challenges of the medical pharmaceutical sector.
In this context, Janez Twin was created as a concrete expression of Sol.i.Pharma’s vision: a system for the automated compounding of injectable chemotherapy therapies, designed to operate in ISO Class 5 controlled environments, with the highest standards of safety, reliability, and precision.
Concrete innovation, operational safety, and reliability for hospital pharmacy.
To bring a second-generation robotic system to serve a modern and efficient hospital pharmacy, combining our automation with the real needs of those who prepare oncology therapies every day.
Overcoming the limits of manual compounding is the first step toward a faster, safer, and more sustainable hospital pharmacy. The future of pharmaceutical automation starts here.
The integration of artificial intelligence into hospital pharmaceutical processes is transforming the management of high-complexity therapies. From the automated preparation of antiblastic drugs to gravimetric control, AI enables greater precision, operational safety, and continuity in critical processes.
Automation reduces human risk, improves efficiency, and ensures complete traceability, making its impact in modern oncology pharmacies impossible to ignore.
Discover how Sol.i.Pharma solutions improve safety, precision, and traceability in the preparation of antiblastic drugs. Contact us to evaluate integration within your clinical processes.
